Chimeric peptides targeting the receptor-binding domain of SARS-CoV-2 variants inhibit ACE2 interaction

The receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein is pivotal in facilitating viral entry and serves as a major target for vaccine development and therapeutics. Despite undergoing mutations aimed at evading host immunity, certain regions within the RBD remain conserved. This study...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Asian Pacific journal of allergy and immunology 2024-11
Hauptverfasser:	Ubonsri, Pisit, Panmanee, Jiraporn, Meewan, Ittipat, Masrinoul, Promsin, Komaikul, Jukrapun, Piboonpocanun, Surapon
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!